Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Œsophage » Néoplasie

30. Mai 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Troubles de la motilité

Écriture:

Page 1 de 1946


	Articles 1 - 20 / 38916

	Fusobacterium nucleatum in cancer: Interactions with microbiota, tumour colonisation and cancer progression. Clin Transl Med Zhao F, An R, Yu S, Ma Y, Liu W, Sheng C, Xie X, Zhang J. PMID: 42212696 [PubMed - indexed for MEDLINE]
	Radiotherapy plus immunotherapy with or without chemotherapy improves survival in elderly esophageal squamous cell carcinoma: a real-world comorbidity-stratified study. Front Oncol Ren HJ, Ren QL, Zhang ZJ, Lei JJ, Xu N. PMID: 42211496 [PubMed]
	LRF-CNN: An explainable lightweight receptive field-based CNN for colorectal cancer histopathological image classification. iScience Yuan L, Li C, Zhang J, Sun H, Rahaman M, Grzegorzek M, Li X. PMID: 42211130 [PubMed]
	The effectiveness of intraoperative indocyanine green fluorescence imaging in preventing anastomotic leakage after minimally invasive esophagectomy for esophageal cancer: a systematic review and meta-analysis. Front Med (Lausanne) Li YH, Qiu JH, Zhang Z, Miao TR, Li YM, Tian H. PMID: 42210944 [PubMed]
	Revisiting Thoracic Duct Resection in Esophageal Squamous Cell Carcinoma: A Propensity-Matched Analysis and Immunologic Insight Into Recurrence Risk. Thorac Cancer Zhang X, Liu XY, Lv YJ, Li SN, Ao Y, Zhong LQ, Hu Y. PMID: 42206574 [PubMed - indexed for MEDLINE]
	Induction immunochemotherapy followed by concurrent chemoradiotherapy improves survival in unresectable esophageal cancer: a systematic review, meta-analysis, and network meta-analysis. Front Immunol Fan X, Liu X, Mi S, Yang Y, Li C, Zhang J, Hu P. PMID: 42206035 [PubMed - indexed for MEDLINE]
	A phase II study of pembrolizumab plus chemotherapy with short-course radiotherapy as induction treatment for unresectable locally advanced esophageal squamous cell carcinoma: PALADIN trial. ESMO Gastrointest Oncol Okemoto D, Kotani D, Nakamura M, Sato K, Kubo Y, Kadota T, Mishima S, Sakashita S, Hashimoto T, Bando H, Wakabayashi M, Rabinowitz M, Liu MC, Jurdi A, Yamaguchi T, Nishikawa H, Shitara K, Yano T, Kojima T, Fujita T. PMID: 42205796 [PubMed]
	Identification of serum 5'tRF-Val as a promising non-invasive biomarker for early detection of esophageal cancer. Sci Rep Zhang L, Zi B, Hong J, Chen Y, Ju S, Jing R, Cui M, Cheng C. PMID: 42204280 [PubMed - as supplied by publisher]
	First-In-Human Study: Dose Expansion of E7130 in Urothelial Carcinoma and Squamous Cell Carcinoma of the Head and Neck. Cancer Sci Matsubara N, Saijo K, Shimizu Y, Okano S, Nakano K, Nishio N, Otsuka T, Kuno H, Miura T, Kubota T, Ikezawa H, Umetsu Y, Ito K, Apfel A, Ye Y, Honma Y. PMID: 42203677 [PubMed - as supplied by publisher]
	Effectiveness of Chemotherapy With/Without Radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Population-based Target Trial Emulation Study. Anticancer Res Lin CY, Lin YS, Fang HY, Wang CC, Liang JA, Li CC, Chien CR. PMID: 42203356 [PubMed - indexed for MEDLINE]
	Value-based pricing of tislelizumab plus chemotherapy versus chemotherapy alone for advanced oesophageal squamous cell carcinoma: a Markov modelling study from the US payer perspective. BMJ Open Abdeen AA, Ayer T, Lim F, Shue S, Hur C. PMID: 42203284 [PubMed - indexed for MEDLINE]
	Zanidatamab with and without Tislelizumab in HER2-Positive Gastroesophageal Cancer. N Engl J Med Shitara K, Elimova E, Liu T, Tabernero J, Lee KW, Schenker M, Tebbutt NC, Ajani J, Salimin N, Ku G, Gwang Kim J, Ales Diaz I, Zhang J, Pietrantonio F, Bai LY, Le Sourd S, Zhao J, Hierro C, Kiberu A, Van Herpe F, Bao Y, Zhang H, Yang L, Li V, Gartner EM, Chen Y, Grim J, Rha SY, Shen L, HERIZON-GEA-01 Investigators. PMID: 42202319 [PubMed - indexed for MEDLINE]
	Early Tumor Shrinkage and Clinical Outcomes for Esophageal Squamous Cell Carcinoma Patients Treated with Immune Checkpoint Inhibitors: Real-World Observational Study. Ann Surg Oncol Kosumi K, Harada K, Shimogawa T, Tsubakihara H, Hara Y, Matsumoto C, Yamashita K, Ohuchi M, Eto K, Ogawa K, Ida S, Hiyoshi Y, Nagai Y, Baba Y, Miyamoto Y, Yoshida N, Iwatsuki M. PMID: 42201494 [PubMed - as supplied by publisher]
	Prognostic significance of the CRP-albumin-lymphocyte (CALLY) index in esophageal cancer: systematic review and meta-analysis. PeerJ Xu W, Zhan D, Wang R, Jin S, Liu XB. PMID: 42199834 [PubMed - indexed for MEDLINE]
	Hollow Cu(2-x)Se/PDA/IR820 Composite Nanoparticles with pH Response for Multimodal Synergistic Treatment of Esophageal Cancer. Int J Nanomedicine Ma F, Ji A, Ma B, Yang P, Li J, Liao S, Yao H, Xie X, Wang Z, Shi L, Gao S, Hou X. PMID: 42199656 [PubMed - indexed for MEDLINE]
	Angiotensin inhibitors during neoadjuvant chemotherapy improve esophageal squamous cell carcinoma outcomes. Ther Adv Med Oncol Chen M, Huang Y, Liu F, Lin C, Zhang S, Zeng T, Yu J, Zheng B, Chen C. PMID: 42199486 [PubMed]
	Interpretable survival modeling integrating nutritional-inflammatory biomarkers in elderly patients with locally advanced esophageal squamous cell carcinoma treated with definitive radiotherapy. Front Immunol Zou J, Fan W, Xia X, Zhang M, Han T, Wu Q. PMID: 42199434 [PubMed - indexed for MEDLINE]
	First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis. Medicina (Kaunas) Seyyar M, Can , Sakin A, Bayramgil A, Dülgar Kaya Ö, Sünger E, Aç, Demir T, Türkel R, Y, Özalp FR, Semiz HS, Y, Aykan MB, Turhan G, Y, Menek, Kut E, Çakmak M, Alg, , Karakayal, O, Artaç M, , Paçac, Sar, , Guliyev M, Demirci NS, Çavdar E, Elçiçek ÖF, , Bölek H, Kubilay Tolunay P, Kalem A, Yaz, Merç Çetinkaya A, Akba, Biter S, Kitapl, Özkan MK, , Majidova N, Arak H, Y, Çabuk D, Uygun K, Sezgin Göksu S, Tanr, Selçukbiricik F, Uzun M, Ökten , Mete B, Kö, Bilici A, Ku, Dizdar Ö, Yalç, Kefeli U. PMID: 42195237 [PubMed - indexed for MEDLINE]
	State-of-the-Art Mediastinal Staging in Non-Small-Cell Lung Cancer: Integration of Combined Endosonographic Techniques with Updated IASLC TNM 9th Classification. Cancers (Basel) Alkathiri O, Liberman M. PMID: 42193023 [PubMed]
	Efficacy of Spectral-Aided Visual Enhancer in Classification of Esophageal Cancer. Cancers (Basel) Koh KY, Mukundan A, Karmakar R, Atulbhai CT, Chen TH, Weng WC, Wang HC. PMID: 42192971 [PubMed]

Articles 1 - 20 / 38916

Page 1 de 1946



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité